The Synergistic Antitumor Effect of Irinotecan and Flavonoids on Human Colon Cancer Xenograft Mice
Abstract ID 53806 Poster Board 44 Camptothecin (CPT)-11 (irinotecan), a DNA topoisomerase I inhibitor, is one of the first-line therapeutic agents in the treatment of metastatic colorectal cancer, but its efficacy and safety can be compromised because of its severe side effects, such as gastrointest...
Gespeichert in:
Veröffentlicht in: | The Journal of pharmacology and experimental therapeutics 2023-06, Vol.385, p.44-44 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!